{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:02:42Z","timestamp":1788832962898,"version":"build-2803163510"},"reference-count":70,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"no funding for this manuscript"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.1080\/1744666x.2021.1967747","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T03:36:42Z","timestamp":1629085002000},"page":"937-945","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4062-9412","authenticated-orcid":false,"given":"Juan M.","family":"Mej\u00eda-Vilet","sequence":"first","affiliation":[{"name":"Instituto Nacional De Ciencias M\u00e9dicas Y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1782-5095","authenticated-orcid":false,"given":"Juanita","family":"Romero-D\u00edaz","sequence":"additional","affiliation":[{"name":"Instituto Nacional De Ciencias M\u00e9dicas Y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"e_1_3_5_3_1","first-page":"727","volume-title":"Dubois systemic lupus erythematosus","author":"Mejia-Vilet JM","year":"2019","unstructured":"Mejia-Vilet JM, Rovin BH Chapter 59. Epidemiology and management of lupus nephritis. In: Dubois systemic lupus erythematosus. Philadelphia: Elsevier; 2019. p. 727\u2013744."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev311"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080214"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002891"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39594"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22173"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs073"},{"key":"e_1_3_5_10_1","unstructured":"FDA Approves Aurinia Pharmaceuticals\u2019 LUPKYNIS\u2122 (voclosporin) for adult patients with active lupus nephritis. [cited 2021 Jun 2]. Available from: https:\/\/www.businesswire.com\/news\/home\/20210122005501\/en\/FDA-Approves-Aurinia-Pharmaceuticals\u2019-LUPKYNISTM-voclosporin-for-Adult-Patients-with-Active-Lupus-Nephritis"},{"issue":"2","key":"e_1_3_5_11_1","first-page":"S29","article-title":"Lupus nephritis: an historical perspective 1968-1998","volume":"12","author":"Cameron JS","year":"1999","unstructured":"Cameron JS. Lupus nephritis: an historical perspective 1968-1998. J Nephrol. 1999;12(Suppl 2):S29\u201341.","journal-title":"J Nephrol"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V871189"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.622225"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603063141004"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92292-N"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00003"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211663"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10461"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102533"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031855"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431604"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080686"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043731"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101028"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014460"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.1"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216924"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1371592"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"e_1_3_5_30_1","unstructured":"Benlysta - US Food and Drug Administration. [cited 2021 Jun 2]. Available from:\u00a0https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761043lbl.pdf"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.02.913"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317719148"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.5414\/CN109325"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1030"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017030263"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.08.025"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00578-X"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03280807"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216965"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.11.008"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37940"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20666"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00832.x"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02670409"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017080830"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206897"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.131995"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.528"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05040513"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38260"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38037"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S255789"},{"key":"e_1_3_5_53_1","unstructured":"Voclosporin - US Food and Drug Administration. Prescribing information. [cited 2021 Jun 2]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/213716s000lbl.pdf"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.114"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12309"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab022"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1857"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq617"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00184.2016"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00263.x"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0014-9"},{"key":"e_1_3_5_62_1","unstructured":"European Medicines Agency on the agreement of a paediatric investigation plan for voclosporin. [cited 2021 Jun 2]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/pip-decision\/p\/0152\/2019-ema-decision-17-april-2019-agreement-paediatric-investigation-plan-granting-deferral-granting_en.pdf"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007121272"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310365714"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq322"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319842924"},{"issue":"6","key":"e_1_3_5_67_1","first-page":"2003","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell BJ","year":"2003","unstructured":"Nankivell BJ, Borrows RJ, Fung CL-S, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349(6):2003.","journal-title":"N Engl J Med"},{"key":"e_1_3_5_68_1","unstructured":"2021 Kidney Disease Improving Global Outcomes (KDIGO) glomerulonephritis guidelines. [cited 2021 Jun 2]. Available from: https:\/\/kdigo.org\/guidelines\/"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814427"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008060665"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206456"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217178"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2021.1967747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:05:15Z","timestamp":1768201515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2021.1967747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,2]]}},"alternative-id":["10.1080\/1744666X.2021.1967747"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2021.1967747","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}